Uni-Bio Science Group Limited (HKG:0690)
Hong Kong · Delayed Price · Currency is HKD 0.0600
-0.0020 (-3.23%)
Aug 27, 2026, 4:08 PM HKT
Uni-Bio Science Group Financials Overview
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 549.77 | 586.21 | 552.98 | 484.72 | 440.32 | 353.41 |
Revenue Growth | -6.22% | 6.01% | 14.08% | 10.08% | 24.59% | 69.27% |
Gross Profit Gross Profit Growth | 456.18 | 487.56 | 461.07 | 392.82 | 334.88 | 277.01 |
Operating Income Operating Income Growth | 56.02 | 97.23 | 99.65 | 80.88 | 47.24 | -4.83 |
Net Income Net Income Growth | 48.54 | 93.33 | 82.77 | 70.88 | 38.51 | -19.59 |
Earnings Per Share EPS Growth | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | -0.00 |
EPS Growth | -48.14% | 15.73% | 21.44% | 83.35% | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Chemical Pharmaceutical Products Chemical Pharmaceutical Products Growth | 199.76 | 249.62 | 257.87 | 232.49 | 146.67 |
Biological Pharmaceutical Products Biological Pharmaceutical Products Growth | 386.45 | 303.36 | 226.85 | 207.82 | 206.74 |
Total Total Growth | 586.21 | 552.98 | 484.72 | 440.32 | 353.41 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 102.3 | 187.68 | 174.08 | 141.59 | 108.62 | 90.33 |
Total Debt Total Debt Growth | 91.02 | 102.97 | 120.45 | 61.73 | 22.8 | 5.6 |
Net Cash (Debt) Net Cash Growth | 11.29 | 84.71 | 53.63 | 79.87 | 85.82 | 84.73 |
Net Cash Growth | -86.67% | 57.97% | -32.86% | -6.94% | 1.29% | 15.23% |
Net Cash Per Share Net Cash Per Share Growth | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 41.92 | 88.79 | 66.71 | 98.85 | 48.66 | 12.04 |
Capital Expenditures CapEx Growth | -52.23 | -52.23 | -38 | -59.74 | -28.43 | -8.43 |
Free Cash Flow Free Cash Flow Growth | -10.31 | 36.56 | 28.71 | 39.11 | 20.23 | 3.61 |
Free Cash Flow Growth | - | 27.35% | -26.59% | 93.33% | 460.70% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 82.98% | 83.17% | 83.38% | 81.04% | 76.05% | 78.38% |
Operating Margin | 10.19% | 16.59% | 18.02% | 16.69% | 10.73% | -1.37% |
Pretax Margin | 10.95% | 17.32% | 16.49% | 15.66% | 9.83% | -5.66% |
Profit Margin | 8.83% | 15.92% | 14.97% | 14.62% | 8.75% | -5.54% |
FCF Margin | -1.88% | 6.24% | 5.19% | 8.07% | 4.59% | 1.02% |
| Fiscal Year | Current | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Dividend Per Share Dividend Per Share Growth | 0.003 | 0.003 | 0.003 |
Dividend Per Share Growth | 13.00% | 13.00% | - |
Dividend Yield | 5.30% | 2.82% | 4.96% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 7.42 | 7.36 | 4.33 | 6.38 | 11.90 | - |
P/FCF Ratio | - | 18.78 | 12.48 | 11.56 | 22.65 | 147.83 |
PS Ratio | 0.65 | 1.17 | 0.65 | 0.93 | 1.04 | 1.51 |